These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 569015)

  • 1. The proliferative state of clonogenic cells in the Lewis lung tumour after treatment with cytotoxic agents.
    Bateman AE; Steel GG
    Cell Tissue Kinet; 1978 Sep; 11(5):445-54. PubMed ID: 569015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential sensitivity of colony-forming cells of hemopoietic tissue, Lewis lung carcinoma, and B16 melanoma to three nitrosoureas.
    Blackett NM; Courtenay VD; Mayer SM
    Cancer Chemother Rep; 1975; 59(5):929-33. PubMed ID: 1203897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
    Stephens TC; Adams K; Peacock JH
    Br J Cancer; 1986 Feb; 53(2):237-45. PubMed ID: 3954945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
    Stephens TC; Peacock JH
    Br J Cancer; 1977 Sep; 36(3):313-21. PubMed ID: 921888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of mechanism of action studies of the nitrosoureas.
    Bono VH
    Cancer Treat Rep; 1976 Jun; 60(6):699-702. PubMed ID: 182364
    [No Abstract]   [Full Text] [Related]  

  • 6. Synergism and schedule dependent cytotoxicity of cyclophosphamide and CCNU in experimental cancer chemotherapy.
    Mulder JH; Edelstein MB; Lelieveld P; van Putten IM
    Eur J Cancer (1965); 1978 May; 14(5):537-42. PubMed ID: 648568
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour.
    Stanley JA; Shipley WU; Steel GG
    Br J Cancer; 1977 Jul; 36(1):105-13. PubMed ID: 889677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
    Hirst DG; Brown JM; Hazlehurst JL
    Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of exponentially growing, stationary-phase, and synchronized cultured human colon carcinoma cells to treatment with nitrosourea derivatives.
    Drewinko B; Barlogie B; Freireich EJ
    Cancer Res; 1979 Jul; 39(7 Pt 1):2630-6. PubMed ID: 445465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple method for producing different growth fractions in vitro for use in anti-cancer drug studies.
    Barranco SC; Bolton WE; Novak JK
    Cell Tissue Kinet; 1979 Jan; 12(1):11-6. PubMed ID: 570456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental factors in glial tumor response to 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea: effect of cell confluence.
    Maker HS; Syed HH; Lehrer GM
    J Natl Cancer Inst; 1977 Nov; 59(5):1427-9. PubMed ID: 909105
    [No Abstract]   [Full Text] [Related]  

  • 12. A soft agar colony assay for Lewis lung tumour and B16 melanoma taken directly from the mouse.
    Courtenay VD
    Br J Cancer; 1976 Jul; 34(1):39-45. PubMed ID: 782495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide.
    Twentyman PR
    Br J Cancer; 1977 Feb; 35(2):208-17. PubMed ID: 836758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and reduction of sister chromatid exchange by CCNU in human lymphocytes in vitro.
    McKenzie WH; Lambert B
    Cancer Genet Cytogenet; 1983 Jul; 9(3):261-71. PubMed ID: 6861116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of isocyanates in the toxicity of antitumour haloalkylnitrosoureas.
    Gibson NW; Hickman JA
    Biochem Pharmacol; 1982 Sep; 31(17):2795-800. PubMed ID: 7138575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous assay by six methods of the effect on haemopoietic precursor cells of adriamycin, methyl CCNU, 60Co gamma-rays, vinblastine, and cytosine arabinoside.
    Blackett NM; Marsh JC; Gordon MY; Okell SF; Aguado M
    Exp Hematol; 1978 Jan; 6(1):2-8. PubMed ID: 342260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis.
    Shih WW; Baumhefner RW; Tourtellotte WW; Haskell CM; Korn EL; Fahey JL
    Clin Exp Immunol; 1983 Jul; 53(1):122-32. PubMed ID: 6603303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responses of tumor cell subpopulations to single modality and combined modality therapies.
    Siemann DW; Keng PC
    NCI Monogr; 1988; (6):101-5. PubMed ID: 3127731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase-specific cytotoxicity in vivo of hydroxyurea on murine fibrosarcoma pulmonary nodules.
    Grdina DJ
    Br J Cancer; 1982 Mar; 45(3):438-46. PubMed ID: 7073937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell proliferation in EMT6 tumours treated with single doses of X-rays or hydroxyurea. II. Computer simulations.
    Demeestere M; Rockwell S; Valleron AJ; Frindel E; Tubiana M
    Cell Tissue Kinet; 1980 May; 13(3):309-17. PubMed ID: 7371067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.